Should you buy Tilray stock? (NasdaqGS:TLRY). Let's see how it does in our automated value investing analysis system.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Tilray to reach your target.
| Advantages | Disadvantages | Neutral |
|---|---|---|
| None. |
|
|
| TLRY Price (Tilray stock price per share) |
$4.08 | |
| PE Ratio versus Sector | 100% lower than other Healthcare stocks | |
| PE Ratio versus Industry | 0% lower than other Drug Manufacturers - Specialty & Generic stocks | |
| Free Cash Flow Jitter | 49% |
Open-market buys and sells reported by Tilray's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-08-06T00:00:00 | Gendel Mitchell (Global General Counsel) | Buy | 2,500 | $4.43 |
| 2026-08-04T00:00:00 | Merton Carl A (Chief Financial Officer) | Buy | 10,000 | $4.62 |
| 2026-08-03T00:00:00 | FALTISCHEK DENISE M (Chief Strategy Officer) | Buy | 2,500 | $4.78 |
| 2025-07-31T00:00:00 | Gendel Mitchell (Global General Counsel) | Buy | 6,000 | $0.58 |
| 2025-07-30T00:00:00 | SIMON IRWIN D (President and CEO) | Buy | 165,000 | $0.61 |
| 2025-07-30T00:00:00 | Merton Carl A (Chief Financial Officer) | Buy | 33,500 | $0.60 |
| 2024-11-15T00:00:00 | Merton Carl A (Chief Financial Officer) | Buy | 26,000 | $1.36 |
| 2024-01-17T00:00:00 | FALTISCHEK DENISE M (Chief Strategy Officer) | Buy | 10,000 | $2.05 |
| 2024-01-16T00:00:00 | Gendel Mitchell (Global General Counsel) | Buy | 7,200 | $1.98 |
| 2024-01-12T00:00:00 | Gendel Mitchell (Global General Counsel) | Buy | 5,400 | $1.87 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 18,060,770 shares shorted. With 132,595,586 shares available for purchase and an average trading volume over the past 10 trading days of 3,668,120, it would take at least 4.924 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
Based on our analysis, we believe that you should not buy Tilray right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Advertisement supports free stock analysis content.
Does Tilray have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
We don't yet have enough financial history for Tilray to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.
Most Popular Articles
Should You Sell Stocks in December?
Should You Invest in Insurance Stocks?
What Did Quantitative Easing Do to the Stock Market?
What is a Good Annual Rate of Return?